Medicine research partner Domainex has opened a 7,000 sqft facility at Unity Campus in Sawston – a Cambridge science and technology park encompassing Iconix Park and The Works.
Staff members will be recruited across all disciplines, with an anticipated increase in headcount of up to fifty per cent by the end of 2022.
Dr Tom Mander, CEO of Domainex, said: “On the back of the strong uptake of our services by life science organisations globally over the last two years, the investment into our new facility has allowed us to create a fully dedicated suite of labs to conduct our biology services. We have enjoyed robust growth in this area, especially in our structure-based offerings. This has the added benefit of freeing up space at our closely located Chesterford Research Park site to further expand our chemistry group.
“We are committed to attracting and retaining highly talented people and have embarked on a major recruitment drive to underpin our growth. Coupled with this, we are making significant additional investments in our people’s skills, access to other cutting-edge technologies and in R&D to bring new services to the market. These are fascinating times for Domainex, and at the outset of our 21st year of operations, we have created a strong financial position to continue our organic growth strategy. We enjoy the strong backing of our board and shareholders to build a pre-eminent drug discovery partner.”
Domainex will join an existing community of biomedical companies at the campus, including IONTAS, PhoreMost, Sareum and Liminal BioSciences. With only one suite remaining of circa 9000 sqft at The Works, Howard Group is forging ahead with its plans to deliver an additional 95,000 sq ft of labs and offices across three new buildings. With a planning application currently under review, construction is planned to start this summer.
